Joseph is a member of our Life Sciences patent team.
He has a BSc (Hons) in Cell Biology and PhD in Molecular and Cell Biology, both from the University of Manchester. During his undergraduate degree he spent his third year in Nevada, USA, where he was researching the electrophysiology of the mouse gastrointestinal tract. During his doctoral research, he utilised the CRISPR/Cas9 gene editing technology to study the process of protein reabsorption in the kidney. He also undertook a post-doctoral research position investigating haemorrhagic stroke linked to hypocholesterolemia and genetic risk factors.
Joseph joined Mewburn Ellis LLP in 2019.